Additionally, the presence of CTNNB1 mutations has been associated with a unique molecular subclass of HCC, often characterized by low genomic instability, well-differentiated histology, and persistent telomerase activity, supporting the hypothesis that these mutations may act in concert to sustain tumor progression [128]. The gene discussed is CTNNB1; the disease is hepatocellular carcinoma.